Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York. Show more
477 Madison Avenue, New York, NY, 10022, United States
Capital Markets
Financial Services
Start AI Chat
Market Cap
468.6M
52 Wk Range
$3.01 - $5.78
Previous Close
$3.78
Open
$3.72
Volume
1,668,202
Day Range
$3.72 - $3.99
Enterprise Value
452.2M
Cash
281.9M
Avg Qtr Burn
-8.315M
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|